Impact of concomitant bone-targeted therapies (BTT) on outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) without prior chemotherapy (ctx) treated with abiraterone acetate (AA) or prednisone (P) Meeting Abstract
| Authors: | Saad, F.; Fizazi, K.; Smith, M. R.; Griffin, T. W.; Londhe, A.; Rathkopf, D. E.; Molina, A.; Ryan, C. J. |
| Abstract Title: | Impact of concomitant bone-targeted therapies (BTT) on outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) without prior chemotherapy (ctx) treated with abiraterone acetate (AA) or prednisone (P) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601635 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.5037 |
| Notes: | Meeting Abstract: 5037 -- Source: Wos |
